These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 34809643

  • 1. Severe ileum bleeding following adjuvant capecitabine chemotherapy for locally advanced colon cancer: a case report and review of the literature.
    Zou Y, Liu S, Wu J, Sun Z.
    World J Surg Oncol; 2021 Nov 22; 19(1):332. PubMed ID: 34809643
    [Abstract] [Full Text] [Related]

  • 2. [A Case of Colon Cancer with Suspected DPD Deficiency Causing Severe Adverse Effects following Adjuvant Chemotherapy with Capecitabine].
    Nagahisa S, Watanabe M, Minagi H, Ogawa T, Araki H, Kimura Y, Taniguchi F, Arata T, Katsuda K, Tanakaya K, Aoki H.
    Gan To Kagaku Ryoho; 2021 Dec 22; 48(13):1928-1931. PubMed ID: 35045450
    [Abstract] [Full Text] [Related]

  • 3. Safety and efficacy of a modified XELOX adjuvant regimen for patients with operated stage III colon cancer: a Chinese single-center experience.
    Peng J, Li W, Zhang R, Lin J, Tang J, Wen Y, Lu Z, Wu X, Pan Z.
    Cancer Commun (Lond); 2019 Oct 16; 39(1):59. PubMed ID: 31619288
    [Abstract] [Full Text] [Related]

  • 4. [A Case of Colon Cancer with DPD Deficiency That Showed Severe Myelosuppression by CapeOX Adjuvant Chemotherapy after Colon Resection].
    Watanabe H, Arita S, Takeuchi T, Oshima Y, Koike N.
    Gan To Kagaku Ryoho; 2018 Nov 16; 45(11):1661-1664. PubMed ID: 30449859
    [Abstract] [Full Text] [Related]

  • 5. [Two Cases of Stage Ⅳ Colorectal Cancer with Long-Term Survival following Single-Agent Chemotherapy with Capecitabine-A Case Reports].
    Suda K, Chiku T, Fukuyama M, Shinoda K, Hashiba H, Sano W, Ando K.
    Gan To Kagaku Ryoho; 2022 Dec 16; 49(13):1882-1884. PubMed ID: 36733031
    [Abstract] [Full Text] [Related]

  • 6. Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial.
    Schmoll HJ, Tabernero J, Maroun J, de Braud F, Price T, Van Cutsem E, Hill M, Hoersch S, Rittweger K, Haller DG.
    J Clin Oncol; 2015 Nov 10; 33(32):3733-40. PubMed ID: 26324362
    [Abstract] [Full Text] [Related]

  • 7. Severe Gastrointestinal Disorder Due to Capecitabine Associated with Dihydropyrimidine Dehydrogenase Deficiency: A Case Report and Literature Review.
    Hagiwara Y, Yamamoto Y, Inagaki Y, Tomisaki R, Tsuji M, Fukuda S, Fukuda S, Onoda T, Suzuki H, Niisato Y, Tange Y, Ikeda N, Yamada K, Kobayashi M, Akutsu D, Yamada T, Moriwaki T, Narasaka T, Suzuki H, Tsuchiya K.
    Intern Med; 2022 Aug 15; 61(16):2449-2455. PubMed ID: 35110482
    [Abstract] [Full Text] [Related]

  • 8. Oncologic outcomes after adjuvant chemotherapy with capecitabine compared to 5-fluorouracil/leucovorin for geriatric stage II colon cancer: a retrospective cohort study.
    Lee KY, Park JW, Lee KY, Cho S, Kwon YH, Kim MJ, Ryoo SB, Jeong SY, Park KJ.
    Int J Colorectal Dis; 2019 Apr 15; 34(4):629-639. PubMed ID: 30661101
    [Abstract] [Full Text] [Related]

  • 9. [Clinical observation of XELOX (Capecitabine puls Oxaliplatin): an adjuvant chemotherapy regimen used in stage III colorectal cancer].
    Diao C, Cheng RC, Zhang JM, Wei XP, Su YJ, Liu QY, Xu JB.
    Zhonghua Zhong Liu Za Zhi; 2008 Feb 15; 30(2):147-50. PubMed ID: 18646702
    [Abstract] [Full Text] [Related]

  • 10. Role of colonoscopy in diagnosis of capecitabine associated ileitis: Two case reports.
    Dao AE, Hsu A, Nakshabandi A, Mandaliya R, Nadella S, Sivaraman A, Mattar M, Charabaty A.
    World J Gastrointest Endosc; 2019 May 16; 11(5):383-388. PubMed ID: 31205599
    [Abstract] [Full Text] [Related]

  • 11. Capecitabine-Induced Terminal Ileitis: Case Report and Literature Review.
    Klimko A, Tieranu CG, Olteanu AO, Preda CM, Ionescu EM.
    Cureus; 2021 Apr 21; 13(4):e14621. PubMed ID: 34055501
    [Abstract] [Full Text] [Related]

  • 12. Capecitabine-Associated Terminal Ileitis.
    van Hellemond IEG, Thijs AM, Creemers GJ.
    Case Rep Oncol; 2018 Apr 21; 11(3):654-659. PubMed ID: 30483093
    [Abstract] [Full Text] [Related]

  • 13. Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer.
    Haller DG, Tabernero J, Maroun J, de Braud F, Price T, Van Cutsem E, Hill M, Gilberg F, Rittweger K, Schmoll HJ.
    J Clin Oncol; 2011 Apr 10; 29(11):1465-71. PubMed ID: 21383294
    [Abstract] [Full Text] [Related]

  • 14. [A case of early gastric cancer completely responding to adjuvant chemotherapy for advanced colon cancer].
    Tanaka R, Kameyama H, Nakano M, Ichikawa H, Hanyu T, Nakano M, Ishikawa T, Shimada Y, Sakata J, Kobayashi T, Kosugi S, Minagawa M, Koyama Y, Wakai T.
    Gan To Kagaku Ryoho; 2014 Nov 10; 41(12):2364-6. PubMed ID: 25731524
    [Abstract] [Full Text] [Related]

  • 15. Redefining adjuvant chemotherapy in patients with stage III colon cancer: X-ACT trial.
    Glen H, Cassidy J.
    Expert Rev Anticancer Ther; 2008 Apr 10; 8(4):547-51. PubMed ID: 18402521
    [Abstract] [Full Text] [Related]

  • 16. Safety and Efficacy of Oxaliplatin Doublet Adjuvant Chemotherapy in Elderly Patients With Stage III Colon Cancer.
    Brungs D, Aghmesheh M, de Souza P, Carolan M, Clingan P, Rose J, Ranson M.
    Clin Colorectal Cancer; 2018 Sep 10; 17(3):e549-e555. PubMed ID: 29861156
    [Abstract] [Full Text] [Related]

  • 17. Cost-effectiveness analysis of capecitabine compared with bolus 5-fluorouracil/l-leucovorin for the adjuvant treatment of colon cancer in Japan.
    Shiroiwa T, Fukuda T, Shimozuma K, Ohashi Y, Tsutani K.
    Pharmacoeconomics; 2009 Sep 10; 27(7):597-608. PubMed ID: 19663530
    [Abstract] [Full Text] [Related]

  • 18. [Oral capecitabine as postoperative adjuvant chemotherapy in stage III colon cancer patients].
    Yamaguchi T, Fukuda M, Yasui H, Okazaki S, Kubo K, Tanaka M, Une Y, Setoguchi Y, Hanada K, Moriyama S, Tani M, Murakami T, Okuchi Y, Ogiso S, Hata H, Sakata S, Otani T, Yamato T, Ikai I.
    Gan To Kagaku Ryoho; 2012 Mar 10; 39(3):389-93. PubMed ID: 22421765
    [Abstract] [Full Text] [Related]

  • 19. Feasibility of sequential adjuvant chemotherapy with a 3-month oxaliplatin-based regimen followed by 3 months of capecitabine in patients with stage III and high-risk stage II colorectal cancer: JSWOG-C2 study.
    Tsuruta A, Yamashita K, Tanioka H, Tsuji A, Inukai M, Yamakawa T, Yamatsuji T, Yoshimitsu M, Toyota K, Yamano T, Nagasaka T, Okajima M.
    Drug Des Devel Ther; 2016 Mar 10; 10():3827-3835. PubMed ID: 27920498
    [Abstract] [Full Text] [Related]

  • 20. Renal tubular acidosis secondary to capecitabine, oxaliplatin, and cetuximab treatment in a patient with metastatic colon carcinoma: a case report and review of the literature.
    Sonnenblick A, Meirovitz A.
    Int J Clin Oncol; 2010 Aug 10; 15(4):420-2. PubMed ID: 20217448
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.